NUKLEOMED-M, OOO, Moscow

Accounting reports

Previously

Name	NUKLEOMED-M, OOO
INN	7708819262
KPP	770201001
OGRN	1147746916063
Address	129272, G.MOSKVA, ul. Trifonovskaya, d. 49, pomesch. 3/1

Extract from EGRUL $12 (€10)

Last name, first name & patronymic of the General Director

List of founders

Position of the company

Licenses

Authorized capital

Branches

Complete structure of the extract

Download an extract from EGRUL

We guarantee to provide you with an actual
information extract

OKVED code	Type	Name of activity type
Data on types of economic activities NUKLEOMED-M, OOO according to EGRUL
86.10	Core activity	Hospitals
21.10	Additional activity	Manufacture of manmade fibres
21.20	Additional activity	Manufacturers of drugs and pharmaceuticals and medical products
All types of activities
46.46	Additional activity	Wholesale of pharmaceutical goods
47.73	Additional activity	Retailing drugs in specialized stores (pharmacies)
47.74	Additional activity	Retailing products used for medical purposes, orthopedic goods in specialized stores
47.75	Additional activity	Retailing of cosmetics and personal hygiene products in specialized stores
52.10	Additional activity	Activity Warehousing and storage
52.24	Additional activity	Cargo handling
73.11	Additional activity	Activities of advertising agencies
86.21	Additional activity	General practice
86.23	Additional activity	Dental practice
86.90.9	Additional activity	Other independent activities in health care

Registration information

Registration date	12.08.2014
Registering department	Mezhrayonnaya inspektsiya Federal'noy nalogovoy sluzhby N 46 po g. Moskve

Description

NUKLEOMED-M, OOO (Moscow; INN 7708819262) was registered on 12 Aug 2014. The company's authorized capital as of July 1, 2012 was 12000 rub.

Principal activities of NUKLEOMED-M, OOO: hospitals (86.10), manufacture of manmade fibres (21.10), manufacturers of drugs and pharmaceuticals and medical products (21.20).

Industry

21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
- 21.1 - Pharmaceutical substances
  - 21.10 - Manufacture of manmade fibres
- 21.2 - The production of medicines and materials used in medical purposes
  - 21.20 - Manufacturers of drugs and pharmaceuticals and medical products
46 - Wholesale trade (excluding motor vehicles)
- 46.4 - Wholesale of household goods
  - 46.46 - Wholesale of pharmaceutical goods
47 - Retail trade, except of motor vehicles and motorcycles
- 47.7 - Retail sale of other goods in specialised stores
52 - Warehousing and storage
- 52.1 - Activity Warehousing and storage
  - 52.10 - Activity Warehousing and storage
- 52.2 - Service activities incidental to land transportation
  - 52.24 - Cargo handling
73 - Market and opinion research
- 73.1 - Advertising
  - 73.11 - Activities of advertising agencies
86 - Health service
- 86.2 - Medical and dental practice activities
  - 86.21 - General practice
  - 86.23 - Dental practice
- 86.9 - Health service
  - 86.90 - Activities in the field of medicine other
    - 86.90.9 - Other independent activities in health care
- 86.1 - Activity of hospital organizations
  - 86.10 - Hospitals

Economic indicators

2023

Net profit (RAS) of NUKLEOMED-M, OOO grew over 2023 2.83 times to 1.38 million RUB from 487.00 thousand RUB over 2022, the company informed.

Revenue increased in the accounting period by 11.74% to 5.50 million RUB from 4.92 million RUB over 2022.

2022

Net profit (RAS) of NUKLEOMED-M, OOO dropped in 2022 2.72 times to 487.00 thousand RUB from 1.32 million RUB over the same period in 2021, the company informed.

Revenue decreased in the accounting period by 3.03% to 4.92 million RUB from 5.08 million RUB in 2021.

2021

Net profit (RAS) of NUKLEOMED-M, OOO grew over 2021 4.76 times to 1.32 million RUB from 278.00 thousand RUB over 2020, the company informed.

Revenue increased in the accounting period by 7.52% to 5.08 million RUB from 4.72 million RUB over 2020.

2020

Net profit (RAS) of NUKLEOMED-M, OOO grew over 2020 2.81 times to 278.00 thousand RUB from 99.00 thousand RUB over 2019, the company informed.

Revenue increased in the accounting period by 42.07% to 4.72 million RUB from 3.32 million RUB over 2019.

2019

Net profit (RAS) of NUKLEOMED-M, OOO made up 99.00 thousand RUB over 2019 compared to net loss of 622.00 thousand RUB over 2018, the company informed.

Revenue increased in the accounting period 1.85 times to 3.32 million RUB from 1.80 million RUB over 2018.

2018

Financial Highlights

Revenue and earnings data

Daily subscription $39 (€32)

unlimited access to database "Kontragent"

download any information within 24 hours

Pay online

Companies in the region

Guarantees

We guarantee

provision of
relevant
information

Payment methods

Statistics

Companies

12 337 433

Reports

17 430 596

Rrocessed requests

Extract from EGRUL:

Today, 4:07 PM

Accounting reports:

Today, 4:10 PM